(For all the LIHOP people, here's a bone: "...Medicare has identified
33 types of financial fraud that are possible in the program...")
Posted on Fri, Oct. 07, 2005
By Tony Pugh
Knight Ridder Newspapers
WASHINGTON - Medicare's plan to fight fraud in its new prescription drug benefit is drawing skepticism from experts who say the benefit is too complex to monitor properly and leaves too much discretion to the industries that have fleeced government health programs in the past. With taxpayers and Congress still fuming about the drug benefit's 10-year, $720 billion price tag, Medicare officials can ill-afford to let the program cost spiral due to fraud by doctors, pharmacies, drug companies, drug plans and the firms that administer them.
Medicare has identified 33 types of financial fraud that are possible in the program. Some are as simple as over-reporting the number of prescriptions filled or billing for brand-name drugs when generics are dispensed.
Others are harder to detect, such as fraudulently inflating drug prices and soliciting or receiving a kickback, bribe or rebate in exchange for prescribing certain drugs or including them for coverage by drug plans.
In the past, these kinds of schemes have bilked billions of dollars from such federal health programs as Medicaid and Medicare, forcing cuts in services and increasing costs for patients. On Friday, Medicare announced that eight private companies will have the primary task of policing the drug program.
<
http://www.realcities.com/mld/krwashington/news/nation/12846722.htm>
(more at link above)